278 related articles for article (PubMed ID: 26078255)
21. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
22. Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine.
McCall AL; Cox DJ; Brodows R; Crean J; Johns D; Kovatchev B
Diabetes Technol Ther; 2009 Jun; 11(6):339-44. PubMed ID: 19459761
[TBL] [Abstract][Full Text] [Related]
23. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
24. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
[TBL] [Abstract][Full Text] [Related]
25. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
[TBL] [Abstract][Full Text] [Related]
26. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
[TBL] [Abstract][Full Text] [Related]
27. Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
Lankisch MR; Del Prato S; Dain MP; Mullins P; Owens DR
Prim Care Diabetes; 2016 Feb; 10(1):51-9. PubMed ID: 26150328
[TBL] [Abstract][Full Text] [Related]
28. Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials.
Levine MJ
Curr Diabetes Rev; 2017; 13(4):405-423. PubMed ID: 27296042
[TBL] [Abstract][Full Text] [Related]
29. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
30. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
[TBL] [Abstract][Full Text] [Related]
31. Hypoglycemia in Type 2 Diabetes--More Common Than You Think: A Continuous Glucose Monitoring Study.
Gehlaut RR; Dogbey GY; Schwartz FL; Marling CR; Shubrook JH
J Diabetes Sci Technol; 2015 Apr; 9(5):999-1005. PubMed ID: 25917335
[TBL] [Abstract][Full Text] [Related]
32. Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System.
Felício KM; de Souza ACCB; Neto JFA; de Melo FTC; Carvalho CT; Arbage TP; de Rider Brito HA; Peixoto AS; de Oliveira AF; de Souza Resende F; Reis SS; Motta AR; da Costa Miranda H; Janau LC; Yamada ES; Felicio JS
Curr Diabetes Rev; 2018; 14(4):395-403. PubMed ID: 28618984
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a new measure of blood glucose variability in diabetes.
Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
[TBL] [Abstract][Full Text] [Related]
34. Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia.
Aronson R; Umpierrez G; Stager W; Kovatchev B
Diabetes Obes Metab; 2019 Mar; 21(3):726-731. PubMed ID: 30421545
[TBL] [Abstract][Full Text] [Related]
35. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
[TBL] [Abstract][Full Text] [Related]
36. Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study.
Andersen A; Bagger JI; Sørensen SK; Baldassarre MPA; Pedersen-Bjergaard U; Forman JL; Gislason G; Lindhardt TB; Knop FK; Vilsbøll T
Cardiovasc Diabetol; 2021 Dec; 20(1):241. PubMed ID: 34952579
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.
Li CJ; Li J; Zhang QM; Lv L; Chen R; Lv CF; Yu P; Yu DM
Cardiovasc Diabetol; 2012 Nov; 11():142. PubMed ID: 23153177
[TBL] [Abstract][Full Text] [Related]
38. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
[TBL] [Abstract][Full Text] [Related]
39. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
Hollander P; Cooper J; Bregnhøj J; Pedersen CB
Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
[TBL] [Abstract][Full Text] [Related]
40. Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.
Dungan K; Binkley P; Osei K
J Diabetes Complications; 2016; 30(1):150-4. PubMed ID: 26475503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
